US 12104163
Adeno-associated virus vectors for treatment of Rett syndrome
granted A61KA61K38/185A61K48/005
Quick answer
US patent 12104163 (Adeno-associated virus vectors for treatment of Rett syndrome) held by Sarepta Therapeutics, Inc. expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K38/185, A61K48/005, A61K48/0058, A61K48/0066